Procter & Gamble Hygiene and Health Care Limited is engaged in the manufacturing and selling of branded packaged fast-moving consumer goods in the femcare and healthcare businesses. The company was incorporated in India as Richardson Hindustan Limited in 1964 and was acquired by Procter & Gamble (P&G) in 1985. PGHH is an Indian subsidiary of Procter & Gamble US.
Its portfolio includes WHISPER – India's leading Feminine Hygiene brand, and VICKS – India's No. 1 Health Care brand, along with Old Spice. The company operates through two distinct business segments that serve different consumer needs across India: Health Care Products and Hygiene Products. The Health Care products segment comprises ointments and creams, cough drops, and tablets. The Hygiene products segment comprises feminine hygiene products and other skin care hygiene products.
The healthcare segment focuses on cold and cough remedies, with its flagship brand Vicks offering products like Vicks VapoRub, Vicks Throat Drops, Vicks Action 500 Advanced, Vicks Inhaler, Vicks Baby Rub, and others. The hygiene products segment primarily centers around feminine care, with its popular brand Whisper offering various sanitary napkin options including Whisper Choice XL, Whisper Choice Ultra, and other feminine hygiene products.
The Company's products are sold through retail operations, including mass merchandisers, grocery stores, membership club stores, drug stores, department stores, and high-frequency stores. This extensive distribution network ensures widespread availability of products across urban and rural markets in India.
The company has two manufacturing locations at Goa and Baddi in Himachal Pradesh, and numerous third-party manufacturing partners located across India. The manufacturing setup reflects the company's strategic approach to cost optimization and operational efficiency. The Goa Honda Factory of the company started its operations in 1996 for manufacturing Vicks VapoRub. After two years, in 1998, the Goa Kundiam Factory started its operations for manufacturing Whisper pads.
Over the years, the company has implemented various cost-saving measures to maintain competitiveness. For example, in FY2002, it consolidated its manufacturing operations in Goa from two plants to one plant to save on operational costs. This demonstrates the company's commitment to operational excellence and cost management.
P&G Hygiene has a Market Capitalization of ₹43,491 Crore (down -19.6% in 1 year), with a Revenue of ₹4,306 Crore and a Profit of ₹718 Crore as per the latest available data. The company has shown resilience in its financial performance despite challenging market conditions.
For the quarter ended December 2024, the company reported strong results:
* Net profit of Procter & Gamble Hygiene and Health Care rose 17.34% to ₹268.59 Crore in Q4 2024, as against ₹228.90 Crore during the previous quarter ended December 2023.
* Sales rose 10.20% to ₹1,246.25 Crore in Q4 2024, as against ₹1,130.93 Crore during the previous quarter ended December 2023.
However, for the quarter ended March 2025, the company faced some challenges:
* Net profit of Procter & Gamble Hygiene and Health Care rose 1.12% to ₹156.10 Crore in Q4 FY25, as against ₹154.37 Crore during the previous quarter ended March 2024.
* Sales declined 0.90% to ₹989.13 Crore in Q4 FY25, as against ₹998.15 Crore during the previous quarter ended March 2024.
Key financial metrics as of recent data (May 27, 2025):
* Revenue: ₹1,246.25 Crore as on December 2024 (Q4 2024)
* Net Profit: ₹268.59 Crore as on December 2024 (Q4 2024)
* The PE and PB ratio of P&G Hygiene & Health Care is 64.56 and 49.09, respectively.
The company maintains a consistent dividend policy, demonstrating its commitment to shareholder returns. Procter & Gamble Hygiene & Healthcare announced that the Board of Directors of the Company at its meeting held on February 11, 2025, has recommended an Interim dividend of ₹110 per share (i.e., 1100%), subject to shareholder approval. Additionally, Procter & Gamble Hygiene & Healthcare announced that the Board of Directors of the Company at its meeting held on May 27, 2025, inter alia, have recommended a final dividend of ₹65 per equity Share (i.e., 650%), subject to shareholder approval.
The company operates in highly competitive markets across its product segments. Procter & Gamble Hygiene and Health Care Ltd faces strong competition for each of its product segments: Whisper (sanitary pads), Vicks (healthcare), and Old Spice (men's grooming).
* In the case of Whisper, it faces competition from financially strong MNC players like Johnson & Johnson (Stayfree, Carefree), Kimberly Clark (Kotex), Unicharm (Sofy), and SCA Hygiene (Libresse).
* In the healthcare (cough and cold) category, PGHH's brand (Vicks) faces competition from Reckitt Benckiser (Strepsils), Dabur (Honitus), Halls, Himalaya (Koflet), etc.
Despite intense competition, the company's strong brand equity and market leadership position help maintain its competitive advantage.
In a recent virtual meeting, the company showcased its resilience amid a challenging macroeconomic landscape, reporting a 3% sales increase and a 7% growth in profit after tax, driven by its Integrated Growth Strategy. This approach has not only fostered consistent mid-single-digit sales growth over the past decade but also improved structural margins despite rising costs.
The company remains committed to consumer-centric innovation, particularly in the Feminine Care and Personal Healthcare categories, leveraging advanced supply chain strategies and community engagement initiatives to enhance brand loyalty and address evolving consumer needs.
* Listing date: November 3, 1994
* Chairperson Name: Chittranjan Dua
* Promoter Holding: 70.6% indicates strong promoter confidence in the business.
* The company trades on both NSE and BSE, with the stock symbol of P&G Hygiene & Health Care being NSE: PGHH on the NSE, BSE: 500459 on the BSE, and the ISIN is INE179A01014.
The company's focus on operational efficiency, brand strength, and strategic market positioning continues to drive its performance in the competitive FMCG landscape. Overall, the focus on product superiority and effective retail execution positions the company favorably for sustained growth.
